Kodiak Sciences Inc Common Stock
Symbol: KOD (NASDAQ)
0.00
▼ (-100.00%) -9.480
Company Description:
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $9.48
- Yesterday High: $11.09
- Yesterday Low: $9.17
- Yesterday Volume: 923.71K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: Kodiak Sciences Inc Common Stock
- Website: https://www.kodiak.com
- Listed Date: 2018-10-04
- Location: PALO ALTO, CA
- Market Status: Active
- CIK Number: 0001468748
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $594.24M
- Round Lot: 100
- Outstanding Shares: 52.82M
- Asset Type: CS
RECENT FILINGS FOR KOD
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-19 | SCHEDULE 13G | View |
| 2025-08-13 | 10-Q | View |
| 2025-08-13 | 8-K | View |
| 2025-07-08 | 4 | View |
| 2025-07-08 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-06-17 | 4 | View |
| 2025-06-03 | 8-K | View |
| 2025-05-14 | 10-Q | View |
| 2025-05-14 | 8-K | View |
| 2025-04-29 | SCHEDULE 13G/A | View |
| 2025-04-22 | ARS | View |
| 2025-04-22 | DEFA14A | View |
| 2025-04-22 | DEF 14A | View |
| 2025-03-27 | S-8 | View |
Latest News on KOD